Can I administer intravenous thrombolysis to a patient with posterior circulation stroke presenting within three hours of symptom onset who has a small infarct visible on MRI?

Yes, you can administer IV thrombolysis to this patient with posterior circulation stroke within 3 hours with a small visible infarct on MRI.

Within the 3-hour window, IV alteplase is recommended for eligible patients with acute ischemic stroke regardless of stroke location (anterior or posterior circulation), and early signs of infarct on imaging—regardless of their extent—are not a contraindication to treatment 1.

Key Evidence Supporting Treatment

Time Window and Imaging Findings

The most recent global stroke guidelines (2023) clearly state that IV alteplase (0.9 mg/kg, maximum 90 mg) is recommended for selected patients who can be treated within 4.5 hours of ischemic stroke symptom onset, with treatment initiated as quickly as possible 2. Your patient at 3 hours falls well within this window.

Critically, the 2009 AHA imaging guidelines explicitly state: "Early signs of infarct on CT, regardless of their extent, are not a contraindication to treatment" (Class I, Level of Evidence A) 1. This applies equally to MRI findings. The only imaging contraindication is frank hypodensity involving more than one-third of an MCA territory—which is not relevant to your posterior circulation case with a small infarct 1.

Posterior Circulation Specificity

Multiple sources confirm that intravenous thrombolysis is appropriate as first-line therapy for posterior circulation stroke 3. Recent research demonstrates that:

• IVT in posterior circulation stroke within 3 hours provides significant benefit, with patients treated ≤3 hours showing better outcomes than those treated at 3-4.5 hours 4
• The treatment benefit is maximized within the first 2 hours but extends throughout the 4.5-hour window 5
• Safety profiles are comparable to anterior circulation strokes 5, 6

MRI as the Imaging Modality

MRI can be used if it does not unduly delay the timely administration of IV tPA (Class IIa, Level of Evidence B) 1. In fact, MR-DWI is superior to CT for detecting acute ischemia, particularly for small lesions and those in the posterior fossa 1. The presence of a visible small infarction on DWI does not contraindicate treatment—it confirms the diagnosis of acute ischemia.

Clinical Algorithm for This Patient

1. Confirm eligibility criteria are met:

   • Time from onset <3 hours ✓
   • No intracranial hemorrhage on MRI ✓
   • Blood pressure can be lowered to <185/110 mmHg if needed
   • Blood glucose >50 mg/dL (must be checked) 2
   • No other absolute contraindications (recent surgery, active bleeding, coagulopathy) 7

2. Proceed immediately with IV alteplase:

   • Dose: 0.9 mg/kg (maximum 90 mg)
   • 10% as bolus over 1 minute
   • Remaining 90% infused over 60 minutes 2, 8, 2

3. Do not delay for additional testing beyond glucose and blood pressure management 2

Important Caveats

Common pitfall to avoid: Do not withhold thrombolysis based on the presence of a visible small infarct on MRI. This is a frequent misunderstanding—the visible DWI lesion confirms acute ischemia but does not contraindicate treatment within the time window 1.

Posterior fossa considerations: While CT is less sensitive for posterior fossa lesions, MRI's superior detection actually strengthens your diagnostic confidence and treatment decision 1.

If large vessel occlusion is present: Consider vascular imaging (MRA) if available without delaying tPA, as the patient may also be a candidate for mechanical thrombectomy. However, eligible patients should receive IV thrombolysis even if mechanical thrombectomy is being considered 2, 9.

The evidence strongly supports treating this patient. Time is brain—particularly in posterior circulation strokes where outcomes can be devastating without intervention.